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Abstract
Background—Heart Failure (HF) is an important and growing public health problem in women. 
Risk factors for incident hospitalized HF with preserved (HFpEF) compared to reduced ejection 
fraction (HFrEF) in women, and differences by race/ethnicity, are not well characterized.
Methods and Results—We prospectively evaluated the risk factors for incident hospitalized 
HFpEF and HFrEF in a multi-racial cohort of 42,170 post-menopausal women followed for a 
mean of 13.2 years. Cox regression models with time dependent covariate adjustment were used to 
define risk factors for HFpEF and HFrEF. Differences by race/ethnicity regarding incidence rates, 
baseline risk factors and their population attributable risk percentage (PAR%) were analyzed. Risk 
factors for both HFpEF and HFrEF were as follows: older age, Caucasian race, diabetes, cigarette 
smoking, and hypertension. Obesity, history of coronary heart disease (other than myocardial 
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infarction (MI)), anemia, atrial fibrillation and more than one co-morbidity, were associated with 
HFpEF but not HFrEF. History of MI was associated with HFrEF but not HFpEF. Obesity was 
found to be a more potent risk factor for African American women compared with Caucasian 
women for HFpEF (p for interaction= 0.007). For HFpEF, the PAR% was greatest for hypertension 
(40.9%) followed by obesity (25.8%), with the highest PAR% found in African Americans for 
these risk factors.
Conclusions—In this multi-racial cohort of postmenopausal women, obesity stands out as a 
significant risk factor for HFpEF, with the strongest association in African American women.
Clinical Trial Registration—URL: http://www.clinicaltrials.gov. Unique identifier: 
NCT00000611.
Keywords
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race; ethnicity
Heart failure (HF) is a major and growing public health problem in the United States (U.S.) 
that accounts for over one million hospital admissions per year and affects close to 6 million 
Americans.1 Of patients with incident HF in epidemiological studies, 40% to 71% have HF 
with preserved, rather than reduced, ejection fraction (HFpEF versus HFrEF) and HFpEF is 
more common in women.1–7 HFpEF is increasing in prevalence1 and as opposed to HFrEF, 
limited effective therapy are presently available. In order to guide future therapeutic 
considerations, there is a need to better understand the risk factors and natural history of 
HFpEF.
The epidemiology of HFpEF has largely been studied in Caucasian cohorts.2, 4–7 Some 
existing studies have examined incident HF in multi-ethnic cohorts but without ejection 
fraction data or have studied survival of those with prevalent HFpEF.8–11 As such, there is an 
important need to evaluate risk factors for incident HFpEF and HFrEF, especially in women 
who are understudied.
The Women’s Health Initiative (WHI) recently re-adjudicated HF in a sub-cohort of women 
that differentiates acute from chronic HF and allows for the evaluation of incident 
hospitalized HFpEF and HFrEF.12,13 We therefore sought to identify risk factors for HFpEF 
and HFrEF in women in this sub-cohort and to better understand the role of race/ethnicity in 
explaining any differences in HFpEF and its risk factors. For those HFpEF and HFrEF risk 
factors that were amenable to prevention, we assessed their population attributable risk 
percentage (PAR%) to estimate the amount of HFpEF and HFrEF that could be theoretically 
reduced if these risk factors were eliminated.
Methods
Study Population
The WHI recruited women nationwide in 40 clinical centers between 1993 and 1998. Details 
of the recruitment, baseline questionnaires and examinations performed have been published 
previously. 14–16 Briefly, study participants were women 50 to 79 years of age at baseline 
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who had no terminal illness and were eligible for either the clinical trials or observational 
arm, completed baseline assessments, including several self-administered questionnaires of 
socio-demographic characteristics, medical history, reproductive and menstrual history, 
health behavior and family history of selected diseases. Of the 161,808, postmenopausal 
women in the original cohort, a sub-cohort of 44,174 women, were evaluated for 
hospitalized HF from baseline through January 13, 2015. To allow for evaluation of racial 
and ethnic differences with adequate statistical power, we excluded those whose self-
reported race was Asian/Pacific islander, Native American or unknown race/ethnicity 
(n=1042). To evaluate a disease free cohort, we excluded 505 women with self-reported HF 
at baseline and 444 who had chronic HF upon their first adjudication. The final analytic 
cohort was 42,170 women. This study received Institutional Review Board approval and all 
participants signed informed consents at all 40 clinical centers.
Outcomes
Hospitalized HF was adjudicated based upon self-report of a hospitalization related to HF or 
coronary heart disease (CHD) by trained adjudicators.12,13 Details of the adjudication 
process for acute HF are given in appendix 1. Acute HF with an ejection fraction < 45% was 
considered HFrEF. Acute HF with an ejection fraction ≥ 45% was considered HFpEF. If no 
ejection fraction was available it was classified as HFuEF. We performed an additional 
sensitivity analysis defining HFpEF as an ejection fraction of ≥ 50% and HFrEF as < 50%.
The acute HF classification system utilized in this analysis has been shown to have good 
agreement with other HF epidemiologic algorithms including: Framingham (69.5%), 
modified Boston (63.7%), NHANES (60.9%), Gothenburg (59.5%), ICD-9-CM (62.9%) and 
demonstrate modest kappa coefficients (0.32–0.10).12
Clinical covariates
Race/ethnicity was self-reported as black or African American, Hispanic/Latino, white or 
Caucasian (not of Hispanic origin), or other.14,15 Clinical covariates include: age, education, 
income, cigarette smoking, current hormone use, hypertension, diabetes mellitus, atrial 
fibrillation, coronary heart disease, chronic lung disease, physical activity, medication use, 
alcohol use, co-morbid conditions, and anemia. Details can be found in appendix 2.
Statistical Methods
Baseline characteristics are reported separately by race/ethnicity, and due to differences in 
age in the race/ethnicity groups, percentages are adjusted to the five-year age distribution of 
the HT participants. Annualized event rates were also age-adjusted as above; with 95% 
confidence intervals computed using a bootstrap method with 5,000 repetitions.
Primary analyses used time-to-event methods based on the Cox regression model. Time is 
defined as days from randomization in the HT, or from WHI enrollment for non-HT 
participants to the event or censoring. Censoring is the earliest of HF of a different type, 
death, end-of-follow-up, or January 13, 2015. All models were stratified by study 
component (clinical trial or observational study), and age strata used for clinical trial 
randomization. Cox regression models use the Wald chi-square test to evaluate the effect of 
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each individual variable while simultaneously adjusting for all variables in the model. Tests 
for interactions are based on likelihood ratio tests. PAR% were calculated using the standard 
definitions.17
Results
Of the sub-cohort of 42,170 women evaluated for incident hospitalized HF, 51.2% were 
Caucasian, 33.6% were African American and 15.2%, were Hispanic. At baseline, African 
American and Hispanic women were younger than Caucasian women; therefore age-
adjusted baseline comparisons have been made. (Table 1) African American women had 
lower incomes, were more likely to be obese, less physically active, and had higher 
prevalence of hypertension, diabetes, CHD, myocardial infarction (MI), stroke than their 
Caucasian counterparts. In addition, African American women were more likely to have had 
a hysterectomy, have anemia, and less likely to be on aspirin. Hispanic women were less 
educated, had lower incomes, had less health insurance, more likely to have diabetes and 
have had a hysterectomy and were less likely to be current smokers and to take aspirin than 
Caucasian women.
Of the 42,170 women, followed for a mean of 13.2 years, there were 1952 cases of acute 
incident hospitalized HF. Of these 1952 cases, 70.7% had troponin measures, 38.9% had 
BNP and 6.1% had NT Pro-BNP assessed. Ejection fraction was determined at the time of 
HF hospitalization in 1419 cases (73%). Of these, 85% were determined by transthoracic 
echocardiogram, 1% by radionucleotide ventriculogram, 11% by angiography, 1% by stress 
echo, and 2% by transesophageal echocardiogram.
Of the 1952 cases of acute incident hospitalized HF, 902 (46.2%) met the definition of 
HFpEF, 508 (26.0%) were HFrEF, 533 (27.3%) were of unknown ejection fraction and 9 
cases initially had a reduced ejection fraction which improved to normal. Annualized 
incidence rates were 0.35% for incident hospitalized HF, 0.16% for HFpEF and 0.09% for 
HFrEF with higher incident rates for HFpEF, compared to HFrEF for all race/ethnicity 
groups. Caucasian women were more likely to develop both HFpEF and HFrEF compared to 
African American and Hispanic women, with age-adjusted annualized incidence (%) and 
95% CI of 0.20 (0.18, 0.21) for HFpEF and 0.10 (0.09,0.11) for HFrEF for Caucasian 
women, 0.0.15 (0.13,0.17) for HFpEF, 0.10(0.08,0.12) for HFrEF for African American 
women and 0.08 (0.06,0.010) for HFpEF, and 0.05 (0.03,0.07) for HFrEF for Hispanic 
women.
Risk factors for HFpEF compared to HFrEF
We examined risk factors for hospitalized incident HFpEF and HFrEF (Table 2). Compared 
to Caucasian women Hispanic women had a lower risk for both HFpEF and HFrEF in fully 
adjusted models, while African American women had a lower risk of HFpEF. Risk factors 
for both incident hospitalized HFpEF and HFrEF were older age, hypertension, diabetes at 
baseline and interim diabetes, current smoking, and interim MI, CHD and cancer. Anemia 
had a similar increased magnitude of risk for HFpEF and HFrEF but didn’t reach statistical 
significance for HFrEF. Risk factors of incident hospitalized HFpEF, but not HFrEF, were 
obesity, history of CHD other than MI, more than one co-morbidity, and hysterectomy with 
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partial oophorectomy but not bilateral oophorectomy and atrial fibrillation. Risk factors for 
HFrEF and not HFpEF were history of MI and elevated heart rate was of borderline 
significance.
Differences in HFpEF between African American, Hispanic American and Caucasian 
women
We evaluated risk factors for incident hospitalized HFpEF and HFrEF stratified by race/
ethnicity. (Table 2) Most risk factors were similar between the three race groups except for a 
significant interaction with obesity (p=0.007). Compared to BMI <25 kg/m2, BMI categories 
30–34.9, and ≥35kg/m2 placed African American women at greater risk for HFpEF (HR= 
6.27, 95% CI 2.49, 15.77; HR=7.50, 95% CI 2.96, 18.98) compared to Caucasian women 
(HR= 1.08, 95% CI 0.81, 1.43; HR=2.10, 95%CI 1.57, 2.80). Hispanic women with BMI 
>35 kg/m2also were at a significantly increased risk for HFpEF, HR=4.29,95%CI 1.24, 
14.90).
Population Attributable Risk% for HFpEF and HFrEF
In order to assess the impact of potential preventive strategies for HFpEF and HFrEF, the 
PAR% for risk factors that are amenable to change and prevalent in the population 
(hypertension, obesity, diabetes, and CHD) were calculated. (Figure 1)
For HFpEF, approximately 2/3rds of the PAR% is associated with hypertension and obesity 
while diabetes and CHD make up approximately 1/4th of the PAR%. For African American 
women, hypertension and obesity were associated with over 90% of the PAR% and for 
Hispanic women the same risk factors were associated with approximately 72% of the PAR
%. For HFrEF, hypertension showed the strongest PAR% in all three race/ethnicity groups.
Discussion
This study of incident hospitalized HFpEF and HFrEF in a multi-ethnic cohort of women 
confirms previous findings that HFpEF is of greater incidence than HFrEF in post-
menopausal women and that risk factors for both HFpEF and HFrEF include age, CHD, 
diabetes, smoking and hypertension. Robust associations for HFpEF, but not HFrEF, include 
obesity, number of co-morbid conditions, anemia and atrial fibrillation. As expected, MI is a 
risk factor for HFrEF. This study is unique in describing the importance of obesity as a risk 
factor for HFpEF and its PAR%, with special significance for African American women. 
While the important role of hypertension as a risk factor for both HFpEF and HFrEF is well 
documented, the important role of obesity as a risk factor in women for HFpEF is less well 
known.
Ho et al18 found a similar result for obesity as a risk factor for incident HFpEF in both sexes 
in the Framingham Heart study, as did Gupta et al11 in the Atherosclerosis Risk in 
Communities study for prevalent HFpEF in African Americans. Lam et al found stronger 
association of obesity in women compared to men in the baseline assessment of participants 
in the I-PRESERVE trial.19 Browers et al in the Dutch Prevend study found obesity to be a 
risk factor for both HFpEF and HFrEF.20 The pathophysiologic mechanisms by which 
higher BMI levels are associated with higher rates of incident HFpEF may well be related to 
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adverse effects on obesity on skeletal muscle, oxidative stress, inflammation, and insulin 
resistance, all contributors to HFpEF.21 Recently Paulus and Tschope22 have proposed that 
obesity through the above mechanisms may induce changes in the coronary microvascular 
endothelium while Mohammed et al 23 has shown associations with coronary microvascular 
rarefaction with HFpEF as another potential mechanism.
While overweight and obesity are risk factors for incident HF and for HFpEF in most 
studies, both Haas et al and Kao have demonstrated in the I-PRESERVE and CHARM 
preserved trials that HFpEF participants with either lower BMIs and higher BMIs predicted 
more cardiovascular events and decreased survival.24, 25 This apparent paradox might be 
explained by cardiac cachexia and nutritional deficiencies associated with lower BMI26 
while a BMI > 35kg/m2 is associated with higher rates of glucose intolerance, metabolic 
syndrome, chronic inflammation, all of which contribute to worse cardiovascular outcomes 
and higher levels of mortality.21
The importance of overweight and obesity in the potential prevention of HFpEF in women, 
especially in African American women, is noteworthy given its high PAR%. Why 
overweight and obesity places African American women at higher risk for HFpEF compared 
to Caucasian women even when adjusting for diabetes and hypertension is unknown but 
differences in inflammatory obesity, insulin sensitivity, and visceral fat distribution might 
play a role in these findings. The potential synergy between weight loss and exercise in 
obese, sedentary women and their impact on the prevention of HFpEF is worthy of future 
trials. Indeed in those with HFpEF, a recent trial showed an improvement in peak oxygen 
consumption with additive effects for weight loss and exercise. 27
Our study is the largest study in post-menopausal women to evaluate clinical risk factors for 
incident hospitalized HF with preserved and reduced ejection fractions and allows for race/
ethnicity comparisons. An additional strength of our study was that it utilized a well 
validated classification system in defining new onset incident hospitalized HF and its 
subtypes.
Our study has several important caveats to consider when evaluating its conclusions. First it 
relied upon hospitalized HF and therefore outpatient diagnosed HF was not captured. 
However outpatient diagnosed HF is less than 25% of HF, is equal distributed between 
HFpEF and HFrEF and leads to subsequent hospitalization within a relatively short period of 
time. 28 In addition, ejection fraction information while captured in the majority of HF 
outcomes was missing in 27%, leading to potential misclassification bias. We may have 
overestimated the frequency of HFrEF by using an EF of <45% compared to a more 
stringent EF of <40% in order to categorize as many participants as either HFpEF or HFrEF 
in our cohort. In addition, the differential association between some risk factors and type of 
heart failure could be due to dependent censoring, although unlikely. We performed a 
sensitivity analysis using ≥50% ejection fraction defining HFpEF and <50% defining HFrEF 
and found similar results. We have limited power in our comparison of risk factors for 
Hispanic American women due to small number of HF events in Hispanic women.
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This study demonstrated the higher incidence rate for new onset hospitalized HFpEF 
compared to HFrEF. Differential risk factors for new onset HFpEF included obesity, number 
of comorbidities, anemia and atrial fibrillation, whereas cigarette smoking, diabetes mellitus, 
hypertension, CHD were risk factors for both types of HF. Obesity was found to be a more 
potent risk factor for African American women compared to Caucasian women for HFpEF 
and showed a trend in Hispanic women. Since HFpEF is growing in incidence and 
prevalence as the population ages, and limited effective treatment for HFpEF are presently 
available, preventive strategies focusing on hypertension and obesity given their high PAR% 
appear most promising.
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Heart failure (HF) is a major and growing public health problem in the United States, 
especially in older women. HFpEF is increasing in prevalence and as opposed to HFrEF, 
limited effective therapy are presently available. In order to guide future therapeutic 
considerations, there is a need to better understand the risk factors and natural history of 
HFpEF compared to HFrEF. This study compared risk factors for incident HFpEF and 
HFrEF and explored differences by race/ethnicity in 42,170 post-menopausal women 
followed for 13 years. Obesity and hypertension were both highly prevalent and extreme 
obesity (BMI>35) was a potent risk factors for HFpEF (HR= 2.36) and not HFrEF 
(HR=1.00) with a stronger association in African American women (HR=7.50) compared 
with Caucasian women (HR=2.10). The association of obesity with HFpEF could be 
associated with the adverse effects of obesity on skeletal muscle, oxidative stress, 
inflammation and insulin resistance which may lead to changes in coronary 
microvascular endothelium or changes in coronary microvascular rarefaction. The reason 
for the differential association of obesity on the risk of HFpEF in African American 
women compared to Caucasian women needs further investigation.
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Figure 1A. Population attributable risk* by race and ethnicity for heart failure with 
preserved ejection fraction
* - sum of PAR % within race/ethnicity may be greater than 100% as incidence rates are not 
adjusted for other risk factors
Figure 1B. Population attributable risk* by race and ethnicity for heart failure with reduced 
ejection fraction
* - sum of PAR % within race/ethnicity may be greater than 100% as incidence rates are not 
adjusted for other risk factors
Eaton et al. Page 11
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